126
Views
23
CrossRef citations to date
0
Altmetric
Articles

Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus

, , , , , , , & show all
Pages 167-170 | Received 18 Jun 2009, Accepted 07 Sep 2009, Published online: 26 Mar 2010

References

  • Della Rossa A, Ferri C, Bombardieri SFrom essential mixed cryoglobulinemia to virus induced autoimmnunity: ten years of research in mixed cryoglobulinemia. In: Shoenfeld Y, editor. The decade of autoimmunity. Amsterdam: Elsevier Sciences, 1999:235–43.
  • Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991;9:621–4.
  • Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999;42:2204–12.
  • Bombardieri S, Della Rossa A. How HCV infection has changed the clinical approach to mixed cryoglobulinemia. Ann Rheum Dis 2007;66(Suppl 2):45.
  • Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis 2008;67:283–7.
  • Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longobardo G, Antonelli A, Mixed cryoglobulinemia: demographic, clinical and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355–74.
  • Mascia MT, Ferrari D, Campioli D, Sandri G, Mussini C, Ferri C. Non HCV-related mixed cryoglobulinemia. Dig Liver Dis 2007;39(Suppl 1):S61–4.
  • Ramos-Casals M, Robles A, Brito-Zeron P, Nardi N, Nicolas MJ, Forns X, Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. Semin Arthritis Rheum 2006;36:189–96.
  • Kallemuchikkal U, Gorevich PD. Evaluation of cryoglobulins. Arch Pathol Lab Med 1999;123:119–25.
  • Wasiuddin AK, Delbert RV, Michael MFComplement and chinins mediators of inflammation. In: Henry JB, editor. Clinical diagnosis and management by laboratory methods, 19th edn. Philadelphia: WB Saunders, 1996:928–46.
  • Erensoy S. Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy. J Clin Virol 2001;21:271–81.
  • Marchi F, Della Rossa A, Tavoni A, Baldini C, d'Ascanio A, Bombardieri S, Efficacy and safety of rituximab in mixed cryoglobulinemia patients. Ann Rheum Dis 2007.
  • Available online at: www.iss.it/site/mortalita/Scripts/SelCause.asp.
  • Bedogni G, Miglioli L, Masutti F, Ferri S, Castiglione A, Lenzi M, Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dyonisos study. Am J Gastroenterol 2008;2103:2248–53.
  • Della Rossa A, Marchi F, Catarsi E, Tavoni A, Bombardieri S. Mortality in mixed cryoglobulinemia: a review of the literature. Clin Exp Rheumatol 2008;26(Suppl 51):S105–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.